初次治疗方法是否影响高级别浆液性卵巢癌的首次复发模式
回顾性研究纳入178例新诊断IIIC-IV期高级别浆液性卵巢癌患者,均实现完全肉眼切除,比较初次肿瘤细胞减灭术(PDS,n=124)与新辅助化疗联合中间型肿瘤细胞减灭术(NACT-IDS,n=54)对首次复发模式的影响。结果显示NACT-IDS与更多复发部位与基线重叠及更少新解剖部位复发相关,且年龄较大、NACT-IDS及基线病变部位更多与复发时间相关。
要点
- NACT-IDS与首次复发时更多部位与基线重叠相关(p≤0.003)。
- NACT-IDS与更少新解剖部位复发相关(p≤0.043)。
- 年龄较大、NACT-IDS及基线病变部位更多与复发时间显著相关(p≤0.018)。
核心结论
- 首次复发时的疾病分布随初次治疗方法的选择而变化,与PDS相比,接受NACT-IDS的患者更常在原发病灶相同部位复发。
研究设计与样本
- 回顾性研究纳入2008年1月至2013年3月新诊断IIIC-IV期高级别浆液性卵巢癌患者178例,均实现完全肉眼切除,其中PDS组124例、IDS组54例,并有基线和首次复发增强CT扫描。
主要发现
- 单因素和多因素分析显示,与PDS相比,NACT-IDS与基线及首次复发之间更多部位重叠相关(p≤0.003),并与新解剖部位复发更少相关(p≤0.043)。
- 在两种治疗方式后接受腹腔内辅助化疗的亚组中,也发现了相同结果。
- 单因素分析显示,患者年龄、初次治疗方法、辅助化疗途径及基线病变部位数量与复发时间相关(p≤0.009)。
- 多因素分析显示,年龄较大、NACT-IDS及基线病变部位更多仍具有显著性(p≤0.018)。
- 在135例发生复发的患者中,分析了基线与复发时疾病部位的重叠及复发时新疾病部位数量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine if the primary treatment approach (primary debulking surgery (PDS) versus neoadjuvant chemotherapy and interval debulking surgery (NACT-IDS)) influences the pattern of first recurrence in patients with completely cytoreduced advanced high-grade serous ovarian carcinoma (HGSOC). MATERIALS AND METHODS: This retrospective study included 178 patients with newly diagnosed stage IIIC-IV HGSOC, complete gross resection during PDS (n = 124) or IDS (n = 54) from January 2008-March 2013, and baseline and first recurrence contrast-enhanced computed tomography scans. Clinical characteristics and number of disease sites at baseline were analyzed for associations with time to recurrence. In 135 patients who experienced recurrence, the overlap in disease locations between baseline and recurrence and the number of new disease locations at recurrence were analyzed according to the primary treatment approach. RESULTS: At univariate and multivariate analyses, NACT-IDS was associated with more overlapping locations between baseline and first recurrence (p ≤ 0.003) and fewer recurrences in new anatomic locations (p ≤ 0.043) compared with PDS. The same results were found in a subgroup that received intra-peritoneal adjuvant chemotherapy after either treatment approach. At univariate analysis, patient age, primary treatment approach, adjuvant chemotherapy route, and number of disease locations at baseline were associated with time to recurrence (p ≤ 0.009). At multivariate analysis, older patient age, NACT-IDS, and greater disease locations at baseline remained significant (p ≤ 0.018). CONCLUSION: The distribution of disease at the time of first recurrence varied with the choice of primary treatment. Compared to patients treated with PDS, patients who underwent NACT-IDS experienced recurrence more often in the same locations as the original disease.
引用
- Himoto Y, Cybulska P, Shitano F, et al. Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer? Gynecol Oncol. 2019. PMID: 31521322. doi:10.1016/j.ygyno.2019.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。